心律調節器的市場規模、佔有率、趨勢分析 (2022~2030年):各產品 (植入式、外置型)、類型 (傳統、MRI支援)、用途 (心律不整、充血性心臟衰竭)、終端用戶、地區
市場調查報告書
商品編碼
1046677

心律調節器的市場規模、佔有率、趨勢分析 (2022~2030年):各產品 (植入式、外置型)、類型 (傳統、MRI支援)、用途 (心律不整、充血性心臟衰竭)、終端用戶、地區

Pacemakers Market Size, Share & Trends Analysis Report By Product (Implantable, External), By Type (Conventional, MRI Compatible), By Application (Arrhythmias, Congestive Heart Failure), By End-use, By Region, And Segment Forecasts, 2022 - 2030

出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

全球心律調節器的市場規模在預測期間內預計以3.4%的年複合成長率發展,2030年成長到59億4,000萬美元的規模。

技術的進步和循環系統系設備的普及率上升,久坐的生活增加,老年人口增加等要素促進該市場的成長。

本報告提供全球心律調節器的市場調查,市場定義和概要,市場影響因素的分析,法律制度,市場規模的變化、預測,類型、產品、用途、終端用戶、地區/主要國家等各種區分的明細,競爭環境,市場佔有率,主要企業簡介等彙整資訊。

目錄

第1章 調查手法、調查範圍

第2章 摘要整理

第3章 心律調節器市場可變因素、趨勢、展望

  • 市場系統預測
  • 普及、成長預測的製圖
  • 市場動態
  • 市場分析工具
  • 法律規範

第4章 競爭環境、業者情勢

  • 進入經營者的分類
  • 上市公司
  • 參與企業詳細內容清單

第5章 COVID-19影響分析

  • 現在及未來的影響分析
  • COVID-19:機會分析

第6章 心律調節器市場:各產品

  • 市場佔有率分析
  • 全球心律調節器市場
    • 植入式心律調節器
    • 外部心律調節器

第7章 心律調節器市場:各類型

  • 市場佔有率分析
  • 全球心律調節器市場
    • MRI互換心律調節器
    • 傳統心律調節器

第8章 心律調節器市場:各用途

  • 市場佔有率分析
  • 全球心律調節器市場
    • 心律不整
    • 充血性心臟衰竭
    • 其他

第9章 心律調節器市場:各終端用戶

  • 市場佔有率分析
  • 全球心律調節器市場
    • 醫院、心臟中心
    • 門診病人手術中心
    • 其他

第10章 心律調節器市場:各地區、產品、類型、用途、終端用戶

  • 地區市場概述
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第11章 企業簡介

  • Osypka Medical GmbH
  • Boston Scientific Corporation
  • Zoll Medical Corporation
  • Medtronic
  • BIOTRONIK
  • MicroPort Scientific Corporation
  • Cook Medical
  • MEDICO SpA
  • Pacetronix
  • Oscor Inc.
Product Code: GVR-1-68038-336-2

Pacemakers Market Growth & Trends:

The global pacemakers market size is anticipated to reach USD 5.94 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a lucrative CAGR of 3.4% from 2022 to 2030. This growth is owing to various factors such as technological advancements and the increasing prevalence of cardiovascular devices. Furthermore, the growing sedentary lifestyle coupled with the rising geriatric population is also anticipated to fuel the market growth during the projected period. During the COVID-19 pandemic, the market experienced a decline in revenues. This is owing to the postponement and cancellation of surgeries. According to the National Center for Biotechnology Information (NCBI), there was around a 73% reduction in de-novo pacemaker implantation during the initial months of the pandemic, which heavily impacted the market.

The increasing prevalence of cardiovascular diseases is a key growth driver for the market. As per the CDC in 2017, CVDs account for about 800,000 deaths in the U.S alone. Moreover, coronary heart disease accounts for the highest number of deaths, followed by stroke and heart failure. As per the British Heart Foundation Centre in 2018, nearly 7.4 million individuals are living with circulatory and heart diseases in the U.K. More than 43,000 individuals under 75 years of age die due to cardiac diseases every year in the U.K. To curb the rising prevalence of CVDs is government bodies and key market players are channelizing revenues to offer a potential treatment. This is anticipated by the influx of advanced products in this market space.

As per the CDC, 2020, more than 15% of U.S. adults are physically inactive that shows the prevalence of adult physical inactivity. Technological developments are quickly renovating the pacemaker market. Key players are focusing on expanding their current portfolio as in January 2020, BIOTRONIK launched an injectable cardiac monitor, BIOMONITOR III in Japan. It is intended to measure irregular heart rhythms with increased clarity. The injectable cardiac monitor also documents the unexplained syncope. Moreover, in November 2021, Abbott revealed the latest data for its Aveir leadless pacemaker for the treatment of patients with abnormal heart rhythms. The data demonstrated that the product if approved would provide various benefits during the treatment of slow heart rhythms.

Pacemakers Market Report Highlights:

  • The market was valued at USD 4.38 billion in 2021 and is expected to witness a CAGR of 3.4% during the forecast period
  • The MRI compatible pacemakers segment is expected to witness the highest CAGR from 2022 to 2030 owing to a higher patient preference rate as 75% of the patients with pacemakers are likely to get MRI during their lifetimes
  • The atrial fibrillation segment held the largest revenue share in 2021 owing to the heightened prevalence of growing with age. As per the National Center for Biotechnology Information, 2020, nearly 6 to 12 million people globally are expected to suffer from atrial fibrillation in the US alone by 2050
  • The biventricular pacemakers segment is expected to grow fast from 2022 to 2030. It is also known as Cardiac Resynchronization Therapy (CRT). An increase in the prevalence of heart failure is one of the major factors driving the demand for biventricular pacemakers
  • Key companies are adopting new strategies to attain a competitive edge. Product development, collaborations, partnerships, mergers and acquisitions, and regional expansion are a few of them

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Estimates And Forecast Timeline
  • 1.2. Research Methodology
  • 1.3. Information procurement
    • 1.3.1. Purchased Database
    • 1.3.2. Gvr's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
    • 1.3.5. Details Of Primary Research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity Flow Analysis(Model 1)
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2
    • 1.9.3. Objective 3
    • 1.9.4. Objective 4

Chapter 2. Executive Summary

  • 2.1. Market Outlook

Chapter 3. Pacemaker Market Variables, Trends, and Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Penetration and Growth Prospect Mapping
  • 3.3. Pacemaker Market Dynamics
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
      • 3.4.1.1. Rising prevalence of cardiovascular diseases(CVD)
      • 3.4.1.2. Favorable reimbursement policies
      • 3.4.1.3. Technological advancements
    • 3.4.2. Market Restraint Analysis
      • 3.4.2.1. Stringent regulation and approvals
      • 3.4.2.2. Product Recalls
    • 3.4.3. Market Opportunity Analysis
    • 3.4.4. Market Challenge Analysis
  • 3.5. Pacemaker: Market Analysis Tools
    • 3.5.1. Industry Analysis-Porter's
    • 3.5.2. SWOT Analysis By Factors(Political & Legal, Economic, Social, And Technological)
  • 3.6. Regulatory Framework

Chapter 4. Competitive & Vendor Landscape

  • 4.1. Participation Categorization
  • 4.2. Public Companies
    • 4.2.1. Company Market Position Analysis
    • 4.2.2. Pacemaker Market: Heat Map Analysis, 2021
  • 4.3. Detailed List of Market Players

Chapter 5. Nebulizer Market: Covid-19 Impact Analysis

  • 5.1. Current And Future Impact Analysis
    • 5.1.1. Disease prevalence Analysis
  • 5.2. Covid-19 Opportunity Analysis
    • 5.2.1. Market entry strategies

Chapter 6. Pacemaker Market: Segment Analysis, By Product, 2017-2030(USD Million)

  • 6.1. Product Market Share Analysis, 2021 & 2030
  • 6.2. Global Pacemaker Market, by Product, 2017 to 2030
    • 6.2.1. Implantable Pacemakers
      • 6.2.1.1. Implantable pacemakers market, 2017-2030(USD Million)
      • 6.2.1.2. Single Chamber
        • 6.2.1.2.1. Single Chamber market, 2017-2030(USD Million)
      • 6.2.1.3. Dual Chamber
        • 6.2.1.3.1. Dual Chamber market, 2017-2030(USD Million)
      • 6.2.1.4. Biventricular Chamber
        • 6.2.1.4.1. Biventricular Chamber market, 2017-2030(USD Million)
    • 6.2.2. External Pacemakers
      • 6.2.2.1. External pacemakers market, 2017-2030(USD Million)

Chapter 7. Pacemaker Market: Segment Analysis, By Type, 2017-2030(USD Million)

  • 7.1. Type Market Share Analysis, 2021 & 2030
  • 7.2. Global Pacemaker Market, by Type, 2017 to 2030
    • 7.2.1. MRI Compatible Pacemakers
      • 7.2.1.1. MRI Compatible Pacemakers market, 2017-2030(USD Million)
    • 7.2.2. Conventional Pacemakers
      • 7.2.2.1. Conventional Pacemakers market, 2017-2030(USD Million)

Chapter 8. Pacemaker Market: Segment Analysis, By Application, 2017-2030(USD Million)

  • 8.1. Application Market Share Analysis, 2021 & 2030
  • 8.2. Global Pacemaker Market, by application, 2017 to 2030
    • 8.2.1. Arrhythmias
      • 8.2.1.1. Arrhythmias market, 2017-2030(USD Million)
      • 8.2.1.2. Atrial Fibrillation
        • 8.2.1.2.1. Atrial Fibrillation market, 2017-2030(USD Million)
      • 8.2.1.3. Heart Block
        • 8.2.1.3.1. Heart Block market, 2017-2030(USD Million)
      • 8.2.1.4. Long QT Syndrome
        • 8.2.1.4.1. Long QT Syndrome market, 2017-2030(USD Million)
    • 8.2.2. Congestive Heart Failure
      • 8.2.2.1. Congestive Heart Failure market, 2017-2030(USD Million)
    • 8.2.3. Others
      • 8.2.3.1. Others market, 2017-2030(USD Million)

Chapter 9. Pacemaker Market: Segment Analysis, By End Use, 2017-2030(USD Million)

  • 9.1. End-use Market Share Analysis, 2021 & 2030
  • 9.2. Global Pacemaker Market, By End Use, 2017 to 2030
    • 9.2.1. Hospitals & Cardiac Centers
      • 9.2.1.1. Hospitals & Cardiac Centers market, 2017-2030(USD Million)
    • 9.2.2. Ambulatory Surgical Centers
      • 9.2.2.1. Ambulatory Surgical Centers Market, 2017-2030(USD Million)
    • 9.2.3. Others
      • 9.2.3.1. Others market, 2017-2030(USD Million)

Chapter 10. Pacemaker Market: Regional Estimates & Trend Analysis, By Product, Type, Application, End Use 2017-2030(USD Million)

  • 10.1. Regional Market Snapshot
  • 10.2. North America
    • 10.2.1. North America Market Estimates And Forecasts, By Country, 2017-2030(USD Million)
    • 10.2.2. U.S.
      • 10.2.2.1. U.S. pacemaker market, 2017-2030(USD Million)
    • 10.2.3. Canada
      • 10.2.3.1. Canada pacemaker market, 2017-2030(USD Million)
  • 10.3. Europe
    • 10.3.1. Europe Pacemaker Market, By Country, 2017-2030(USD Million)
    • 10.3.2. U.K.
      • 10.3.2.1. U.K. pacemaker market, 2017-2030(USD Million)
    • 10.3.3. Germany
      • 10.3.3.1. Germany pacemaker market, 2017-2030(USD Million)
    • 10.3.4. France
      • 10.3.4.1. France pacemaker market, 2017-2030(USD Million)
    • 10.3.5. Italy
      • 10.3.5.1. Italy pacemaker market, 2017-2030(USD Million)
    • 10.3.6. Spain
      • 10.3.6.1. Spain pacemaker market, 2017-2030(USD Million)
  • 10.4. Asia Pacific
    • 10.4.1. Asia Pacific Pacemaker Market, By Country, 2017-2030(USD Million)
    • 10.4.2. Japan
      • 10.4.2.1. Japan pacemaker market, 2017-2030(USD Million)
    • 10.4.3. China
      • 10.4.3.1. China pacemaker market, 2017-2030(USD Million)
    • 10.4.4. India
      • 10.4.4.1. India pacemaker market, 2017-2030(USD Million)
    • 10.4.5. Australia
      • 10.4.5.1. Australia pacemaker market, 2017-2030(USD Million)
  • 10.5. Latin America
    • 10.5.1. Latin America Pacemaker Market, By Country, 2017-2030(USD Million)
    • 10.5.2. Brazil
      • 10.5.2.1. Brazil pacemaker market, 2017-2030(USD Million)
    • 10.5.3. Mexico
      • 10.5.3.1. Mexico pacemaker market, 2017-2030(USD Million)
  • 10.6. MEA
    • 10.6.1. MEA Pacemaker Market, By Country 2017-2030(USD Million)
    • 10.6.2. South Africa
      • 10.6.2.1. South Africa pacemaker market, 2017-2030(USD Million)
    • 10.6.3. Saudi Arabia
      • 10.6.3.1. Saudi Arabia pacemaker market, 2017-2030(USD Million)
    • 10.6.4. UAE
      • 10.6.4.1. UAE pacemaker market, 2017-2030(USD Million)

Chapter 11. Company Profile

  • 11.1. Osypka Medical GmbH
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Strategic Initiatives
  • 11.2. Boston Scientific Corporation
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Strategic Initiatives
  • 11.3. Zoll Medical Corporation
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Strategic Initiatives
  • 11.4. Medtronic
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Strategic Initiatives
  • 11.5. BIOTRONIK
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Strategic Initiatives
  • 11.6. MicroPort Scientific Corporation
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Strategic Initiatives
  • 11.7. Cook Medical
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Strategic Initiatives
  • 11.8. MEDICO SpA
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
  • 11.9. Pacetronix
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
  • 11.10. Oscor Inc.
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking

List of Tables

  • TABLE 1: North America pacemakers market, by product, 2017 - 2030 (USD Million)
  • TABLE 2: North America pacemakers market, by product, by Implantable Pacemakers, 2017 - 2030 (USD Million)
  • TABLE 3: North America pacemakers market, by type, 2017 - 2030 (USD Million)
  • TABLE 4: North America pacemakers market, by application, 2017 - 2030 (USD Million)
  • TABLE 5: North America pacemakers market, by Arrhythmias, by application, 2017 - 2030 (USD Million)
  • TABLE 6: North America pacemakers market, by end-use, 2017 - 2030 (USD Million)
  • TABLE 7: U.S. pacemakers market, by product, 2017 - 2030 (USD Million)
  • TABLE 8: U.S. pacemakers market, by product, by Implantable Pacemakers, 2017 - 2030 (USD Million)
  • TABLE 9: U.S. pacemakers market, by type, 2017 - 2030 (USD Million)
  • TABLE 10: U.S. pacemakers market, by application, 2017 - 2030 (USD Million)
  • TABLE 11: U.S. pacemakers market, by Arrhythmias, by application, 2017 - 2030 (USD Million)
  • TABLE 12: U.S. pacemakers market, by end-use, 2017 - 2030 (USD Million)
  • TABLE 13: Canada pacemakers market, by product, 2017 - 2030 (USD Million)
  • TABLE 14: Canada pacemakers market, by product, by Implantable Pacemakers, 2017 - 2030 (USD Million)
  • TABLE 15: Canada pacemakers market, by type, 2017 - 2030 (USD Million)
  • TABLE 16: Canada pacemakers market, by application, 2017 - 2030 (USD Million)
  • TABLE 17: Canada pacemakers market, by Arrhythmias, by application, 2017 - 2030 (USD Million)
  • TABLE 18: Canada pacemakers market, by end-use, 2017 - 2030 (USD Million)
  • TABLE 19: Europe pacemakers market, by country, 2017 - 2030 (USD Million)
  • TABLE 20: Europe pacemakers market, by product, 2017 - 2030 (USD Million)
  • TABLE 21: Europe pacemakers market, by product, by Implantable pacemakers, 2017 - 2030 (USD Million)
  • TABLE 22: Europe pacemakers market, by type, 2017 - 2030 (USD Million)
  • TABLE 23: Europe pacemakers market, by application, 2017 - 2030 (USD Million)
  • TABLE 24: Europe pacemakers market, by Arrhythmias, by application, 2017 - 2030 (USD Million)
  • TABLE 25: Europe pacemakers market, by end-use, 2017 - 2030 (USD Million)
  • TABLE 26: U.K. pacemakers market, by product, 2017 - 2030 (USD Million)
  • TABLE 27: U.K. pacemakers market, by product, by Implantable pacemakers, 2017 - 2030 (USD Million)
  • TABLE 28: U.K. pacemakers market, by type, 2017 - 2030 (USD Million)
  • TABLE 29: U.K. pacemakers market, by application, 2017 - 2030 (USD Million)
  • TABLE 30: U.K. pacemakers market, by Arrhythmias, by application, 2017 - 2030 (USD Million)
  • TABLE 31: U.K. pacemakers market, by end-use, 2017 - 2030 (USD Million)
  • TABLE 32: Germany pacemakers market, by product, 2017 - 2030 (USD Million)
  • TABLE 33: Germany pacemakers market, by product, by Implantable pacemakers, 2017 - 2030 (USD Million)
  • TABLE 34: Germany pacemakers market, by type, 2017 - 2030 (USD Million)
  • TABLE 35: Germany pacemakers market, by application, 2017 - 2030 (USD Million)
  • TABLE 36: Germany pacemakers market, by Arrhythmias, by application, 2017 - 2030 (USD Million)
  • TABLE 37: Germany pacemakers market, by end-use, 2017 - 2030 (USD Million)
  • TABLE 38: Spain pacemakers market, by product, 2017 - 2030 (USD Million)
  • TABLE 39: Spain pacemakers market, by product, by Implantable pacemakers, 2017 - 2030 (USD Million)
  • TABLE 40: Spain pacemakers market, by type, 2017 - 2030 (USD Million)
  • TABLE 41: Spain pacemakers market, by application, 2017 - 2030 (USD Million)
  • TABLE 42: Spain pacemakers market, by Arrhythmias, by application, 2017 - 2030 (USD Million)
  • TABLE 43: Spain pacemakers market, by end-use, 2017 - 2030 (USD Million)
  • TABLE 44: Italy pacemakers market, by product, 2017 - 2030 (USD Million)
  • TABLE 45: Italy pacemakers market, by product, by Implantable pacemakers 2017 - 2030 (USD Million)
  • TABLE 46: Italy pacemakers market, by type, 2017 - 2030 (USD Million)
  • TABLE 47: Italy pacemakers market, by application, 2017 - 2030 (USD Million)
  • TABLE 48: Italy pacemakers market, by Arrhythmias, by application, 2017 - 2030 (USD Million)
  • TABLE 49: Italy pacemakers market, by end-use, 2017 - 2030 (USD Million)
  • TABLE 50: France pacemakers market, by product, 2017 - 2030 (USD Million)
  • TABLE 51: France pacemakers market, by product, by Implantable pacemakers, 2017 - 2030 (USD Million)
  • TABLE 52: France pacemakers market, by type, 2017 - 2030 (USD Million)
  • TABLE 53: France pacemakers market, by application, 2017 - 2030 (USD Million)
  • TABLE 54: France pacemakers market, by Arrhythmias, by application, 2017 - 2030 (USD Million)
  • TABLE 55: France pacemakers market, by end-use, 2017 - 2030 (USD Million)
  • TABLE 56: Asia Pacific pacemakers market, by country, 2017 - 2030 (USD Million)
  • TABLE 57: Asia Pacific pacemakers market, by product, 2017 - 2030 (USD Million)
  • TABLE 58: Asia Pacific pacemakers market, by Implantable pacemaker, by product, 2017 - 2030 (USD Million)
  • TABLE 59: Asia Pacific pacemakers market, by type, 2017 - 2030 (USD Million)
  • TABLE 60: Asia Pacific pacemakers market, by application, 2017 - 2030 (USD Million)
  • TABLE 61: Asia Pacific pacemakers market, by Arrhythmias, by application, 2017 - 2030 (USD Million)
  • TABLE 62: Asia Pacific pacemakers market, by end-use, 2017 - 2030 (USD Million)
  • TABLE 63: Japan pacemakers market, by product, 2017 - 2030 (USD Million)
  • TABLE 64: Japan pacemakers market, by Implantable product, 2017 - 2030 (USD Million)
  • TABLE 65: Japan pacemakers market, by type, 2017 - 2030 (USD Million)
  • TABLE 66: Japan pacemakers market, by application, 2017 - 2030 (USD Million)
  • TABLE 67: Japan pacemakers market, by Arrhythmias, by application, 2017 - 2030 (USD Million)
  • TABLE 68: Japan pacemakers market, by end-use, 2017 - 2030 (USD Million)
  • TABLE 69: China pacemakers market, by product, 2017 - 2030 (USD Million)
  • TABLE 70: China pacemakers market, by Implantable product, 2017 - 2030 (USD Million)
  • TABLE 71: China pacemakers market, by type, 2017 - 2030 (USD Million)
  • TABLE 72: China pacemakers market, by application, 2017 - 2030 (USD Million)
  • TABLE 73: China pacemakers market, by Arrhythmias, by application, 2017 - 2030 (USD Million)
  • TABLE 74: China pacemakers market, by end-use, 2017 - 2030 (USD Million)
  • TABLE 75: India pacemakers market, by product, 2017 - 2030 (USD Million)
  • TABLE 76: India pacemakers market, by Implantable product, 2017 - 2030 (USD Million)
  • TABLE 77: India pacemakers market, by type, 2017 - 2030 (USD Million)
  • TABLE 78: India pacemakers market, by application, 2017 - 2030 (USD Million)
  • TABLE 79: India pacemakers market, by Arrhythmias, by application, 2017 - 2030 (USD Million)
  • TABLE 80: India pacemakers market, by end-use, 2017 - 2030 (USD Million)
  • TABLE 81: Australia pacemakers market, by product, 2017 - 2030 (USD Million)
  • TABLE 82: Australia pacemakers market, by Implantable product, 2017 - 2030 (USD Million)
  • TABLE 83: Australia China pacemakers market, by application, 2017 - 2030 (USD Million)
  • TABLE 84: Australia pacemakers market, by Arrhythmias, by application, 2017 - 2030 (USD Million)
  • TABLE 85: Australia pacemakers market, by end-use, 2017 - 2030 (USD Million)
  • TABLE 86: LATAM pacemakers market, by country, 2017 - 2030 (USD Million)
  • TABLE 87: LATAM pacemakers market, by product, 2017 - 2030 (USD Million)
  • TABLE 88: LATAM pacemakers market, by Implantable pacemakers, by product, 2017 - 2030 (USD Million)
  • TABLE 89: LATAM pacemakers market, by type, 2017 - 2030 (USD Million)
  • TABLE 90: LATAM pacemakers market, by application, 2017 - 2030 (USD Million)
  • TABLE 91: LATAM pacemakers market, by Arrhythmias, by application, 2017 - 2030 (USD Million)
  • TABLE 92: LATAM pacemakers market, by end-use, 2017 - 2030 (USD Million)
  • TABLE 93: Brazil pacemakers market, by product, 2017 - 2030 (USD Million)
  • TABLE 94: Brazil pacemakers market, by product, by Implantable pacemakers, 2017 - 2030 (USD Million)
  • TABLE 95: Brazil pacemakers market, by type, 2017 - 2030 (USD Million)
  • TABLE 96: Brazil pacemakers market, by application, 2017 - 2030 (USD Million)
  • TABLE 97: Brazil pacemakers market, by Arrhythmias, by application, 2017 - 2030 (USD Million)
  • TABLE 98: Brazil pacemakers market, by end-use, 2017 - 2030 (USD Million)
  • TABLE 99: Mexico pacemakers market, by product, 2017 - 2030 (USD Million)
  • TABLE 100: Mexico pacemakers market, by product, by Implantable pacemakers, 2017 - 2030 (USD Million)
  • TABLE 101: Mexico pacemakers market, by type, 2017 - 2030 (USD Million)
  • TABLE 102: Mexico pacemakers market, by application, 2017 - 2030 (USD Million)
  • TABLE 103: Mexico pacemakers market, by Arrhythmias, by application, 2017 - 2030 (USD Million)
  • TABLE 104: Mexico pacemakers market, by end-use, 2017 - 2030 (USD Million)
  • TABLE 105: MEA pacemakers market, by country, 2017 - 2030 (USD Million)
  • TABLE 106: MEA pacemakers market, by product, 2017 - 2030 (USD Million)
  • TABLE 107: MEA pacemakers market, by product, by Implantable pacemakers, 2017 - 2030 (USD Million)
  • TABLE 108: MEA pacemakers market, by type, 2017 - 2030 (USD Million)
  • TABLE 109: MEA pacemakers market, by application, 2017 - 2030 (USD Million)
  • TABLE 110: MEA pacemakers market, by Arrhythmias, by application, 2017 - 2030 (USD Million)
  • TABLE 111: MEA pacemakers market, by end-use, 2017 - 2030 (USD Million)
  • TABLE 112: South Africa pacemakers market, by product, 2017 - 2030 (USD Million)
  • TABLE 113: South Africa pacemakers market, by product, by Implantable pacemakers, 2017 - 2030 (USD Million)
  • TABLE 114: South Africa pacemakers market, by type, 2017 - 2030 (USD Million)
  • TABLE 115: South Africa pacemakers market, by application, 2017 - 2030 (USD Million)
  • TABLE 116: South Africa pacemakers market, by Arrhythmias, by application, 2017 - 2030 (USD Million)
  • TABLE 117: South Africa pacemakers market, by end-use, 2017 - 2030 (USD Million)
  • TABLE 118: Saudi Arabia pacemakers market, by product, 2017 - 2030 (USD Million)
  • TABLE 119: Saudi Arabia pacemakers market, by product, by Implantable pacemakers, 2017 - 2030 (USD Million)
  • TABLE 120: Saudi Arabia pacemakers market, by type, 2017 - 2030 (USD Million)
  • TABLE 121: Saudi Arabia pacemakers market, by application, 2017 - 2030 (USD Million)
  • TABLE 122: Saudi Arabia pacemakers market, by Arrhythmias, by application, 2017 - 2030 (USD Million)
  • TABLE 123: Saudi Arabia pacemakers market, by end-use, 2017 - 2030 (USD Million)
  • TABLE 124: UAE pacemakers market, by product, 2017 - 2030 (USD Million)
  • TABLE 125: UAE pacemakers market, by product, by Implantable pacemakers, 2017 - 2030 (USD Million)
  • TABLE 126: UAE pacemakers market, by type, 2017 - 2030 (USD Million)
  • TABLE 127: UAE pacemakers market, by application, 2017 - 2030 (USD Million)
  • TABLE 128: UAE pacemakers market, by Arrhythmias, by application, 2017 - 2030 (USD Million)
  • TABLE 129: UAE pacemakers market, by end-use, 2017 - 2030 (USD Million)

List of Figures

  • FIG. 1: Pacemaker market segmentation
  • FIG. 2: Market research process
  • FIG. 3: Information procurement
  • FIG. 4: Primary research pattern
  • FIG. 5: Market research approaches
  • FIG. 6: Value-chain-based sizing & forecasting
  • FIG. 7: Market formulation & validation
  • FIG. 8: Commodity flow analysis
  • FIG. 9: Market outlook (2021, USD Million)
  • FIG. 10: Parent Market, 2021
  • FIG. 11: Ancillary Market, 2021
  • FIG. 12: Penetration and growth prospect mapping
  • FIG. 13: Market trends & outlook
  • FIG. 14: Market driver relevance analysis (Current & future impact)
  • FIG. 15: Market restraint relevance analysis (Current & future impact)
  • FIG. 16: Porter's five forces analysis
  • FIG. 17: SWOT Analysis by Factors (Political & Legal, Economic, Social, and Technological)
  • FIG. 18: Market Participant Categorization
  • FIG. 19: Strategy mapping
  • FIG. 20: Pacemaker market: Heat map analysis, 2021
  • FIG. 21: Pacemaker market: Product movement analysis
  • FIG. 22: Pacemaker market product outlook: Key takeaways
  • FIG. 23: Implantable pacemakers market, 2017 - 2030 (USD Million)
  • FIG. 24: Single chamber market, 2017 - 2030 (USD Million)
  • FIG. 25: Dual-chamber market, 2017 - 2030 (USD Million)
  • FIG. 26: Biventricular chamber market, 2017 - 2030 (USD Million)
  • FIG. 27: External pacemakers market, 2017 - 2030 (USD Million)
  • FIG. 28: Pacemaker market: Type movement analysis
  • FIG. 29: Pacemaker market type outlook: Key takeaways
  • FIG. 30: MRI compatible pacemakers market, 2017 - 2030 (USD Million)
  • FIG. 31: Conventional pacemakers market, 2017 - 2030 (USD Million)
  • FIG. 32: Pacemaker market: Application movement analysis
  • FIG. 33: Pacemaker market application outlook: Key takeaways
  • FIG. 34: Arrhythmias market, 2017 - 2030 (USD Million)
  • FIG. 35: Atrial fibrillation market, 2017 - 2030 (USD Million)
  • FIG. 36: Heart block market, 2017 - 2030 (USD Million)
  • FIG. 37: Long QT syndrome market, 2017 - 2030 (USD Million)
  • FIG. 38: Congestive Heart Failure market, 2017 - 2030 (USD Million)
  • FIG. 39: Others market, 2017 - 2030 (USD Million)
  • FIG. 40: Pacemaker Market: End-use movement analysis
  • FIG. 41: Pacemaker market End-use outlook: Key takeaways
  • FIG. 42: Hospitals & cardiac centers market, 2017 - 2030 (USD Million)
  • FIG. 43: Ambulatory surgical centers market, 2017 - 2030 (USD Million)
  • FIG. 44: Others market, 2017 - 2030 (USD Million)
  • FIG. 45: Regional marketplace: Key takeaways
  • FIG. 46: Pacemaker market: Regional movement analysis
  • FIG. 47: North America pacemaker market, by country, 2017 - 2030 (USD Million)
  • FIG. 48: U.S. pacemaker market, 2017 - 2030 (USD Million)
  • FIG. 49: Canada pacemaker market, 2017 - 2030 (USD Million)
  • FIG. 50: Europe pacemaker market, by country, 2017 - 2030 (USD Million)
  • FIG. 51: U.K. pacemaker market, 2017 - 2030 (USD Million)
  • FIG. 52: Germany pacemaker market, 2017 - 2030 (USD Million)
  • FIG. 53: France pacemaker market, 2017 - 2030 (USD Million)
  • FIG. 54: Italy pacemaker market, 2017 - 2030 (USD Million)
  • FIG. 55: Spain pacemaker market, 2017 - 2030 (USD Million)
  • FIG. 56: Asia Pacific pacemaker market, by country, 2017 - 2030 (USD Million)
  • FIG. 57: Japan pacemaker market, 2017 - 2030 (USD Million)
  • FIG. 58: China pacemaker market, 2017 - 2030 (USD Million)
  • FIG. 59: India pacemaker market, 2017 - 2030 (USD Million)
  • FIG. 60: Australia pacemaker market, 2017 - 2030 (USD Million)
  • FIG. 61: Latin America pacemaker market, by country, 2017 - 2030 (USD Million)
  • FIG. 62: Brazil pacemaker market, 2017 - 2030 (USD Million)
  • FIG. 63: Mexico pacemaker market, 2017 - 2030 (USD Million)
  • FIG. 64: MEA pacemaker market, by country, 2017 - 2030 (USD Million)
  • FIG. 65: South Africa pacemaker market, 2017 - 2030 (USD Million)
  • FIG. 66: Saudi Arabia pacemaker market, 2017 - 2030 (USD Million)
  • FIG. 67: UAE pacemaker market, 2017 - 2030 (USD Million
  • FIG. 68: Competitive dashboard analysis